首页 | 本学科首页   官方微博 | 高级检索  
     

阿奇霉素序贯疗法治疗小儿肺炎支原体肺炎疗效观察
引用本文:曾国庆,刘国英,陈瑞林,彭小斌. 阿奇霉素序贯疗法治疗小儿肺炎支原体肺炎疗效观察[J]. 中国中西医结合儿科学, 2016, 0(1): 46-48. DOI: 10.3969/j.issn.1674-3865.2016.01.018
作者姓名:曾国庆  刘国英  陈瑞林  彭小斌
作者单位:深圳市宝安区福永人民医院儿科, 广东 深圳,518103
摘    要:目的观察阿奇霉素序贯疗法治疗小儿肺炎支原体肺炎的临床效果。方法深圳市宝安区福永人民医院2013年6月至2014年8月收治肺炎支原体肺炎患儿96例,随机分为对照组和观察组各48例。对照组采用红霉素序贯疗法,给予红霉素注射液静脉滴注,每日1次,持续治疗5d后,改用红霉素片口服,每日3次,持续治疗7d。观察组采用阿奇霉素序贯疗法,给予阿奇霉素注射液静脉滴注,每日1次,治疗5d后,停药4d,改为阿奇霉素干混悬剂口服,每日1次,持续给药3d。观察两组患儿治疗效果及不良反应发生情况。结果观察组患儿总有效率为97.9%(47/48),高于对照组85.4%(41/48),差异有统计学意义(P0.05)。观察组不良反应发生率为14.6%(7/48),低于对照组27.1%(13/48),差异有统计学意义(P0.05)。结论在小儿肺炎支原体肺炎治疗中,阿奇霉素序贯疗法能明显改善临床症状,具有见效快、不良反应少等优势,疗效安全显著,最大程度减轻患儿痛苦,提高患儿生活质量,值得临床推广应用。

关 键 词:肺炎,支原体  红霉素  阿奇霉素  序贯疗法  临床效果  儿童

Observation of clinical effects of azithromycin sequential therapy for children with mycoplasma pneumonia
Abstract:Objective To observe the clinical effects of azithromycin sequential therapy for children with mycoplasma pneumonia.Methods Totally 96 children with mycoplasma pneumonia who received treat-ments in Fuyong People's Hospital from June 2013 to August 2014 were taken as the research subjects,and these patients were randomly divided into the control group and the observation group,with 48 patients in each group.In the control group,they were treated with the erythromycin sequential therapy:erythromycin injection was administered intravenously once a day,continuously for 5 days,and then they were treated with the erythromycin tablets orally,3 times a day,continuously for 7 days;in the observation group,they were treated with the azithromycin sequential therapy,azithromycin injection for intravenous drip,once a day,and 5 days later the treatment was stopped for 4 days,and then azithromycin dry suspension was given orally, once a day,continuously for 3 days.Then,the treatment effect and adverse reaction of the two groups were observed.Results The total effective rate in observation group was 97.9%(47/48),which was higher than that in the control group [85.4%(41/48)],and the difference was statistically significant(P <0.05).The incidence rate of adverse reactions in the observation group was 14.6% (7/48),which was lower than that in the control group [27.1%(13/48)],and the difference was statistically significant(P < 0.05 ).Conclusion In the treatment of children with mycoplasma pneumonia,the azithromycin sequential therapy can significantly improve the clini-cal symptoms,and it has quick effect and fewer adverse reactions with other advantages;it is safe with signif-icant effect and it can greatly reduce the pain and improve the quality of life of children,thus it should be promoted in the clinical application.
Keywords:Pneumonia,mycoplasma  Erythromycin  Azithromycin  Sequential therapy  Clin-ical effect  Children
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号